Cell proliferation in 3,800 node-negative breast cancers: Concistency over time of biological and clinical information provided by3H-Thymidine labelling index
- 20 February 1997
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 74 (1) , 122-127
- https://doi.org/10.1002/(sici)1097-0215(19970220)74:1<122::aid-ijc20>3.0.co;2-g
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Do we really need prognostic factors for breast cancer?Breast Cancer Research and Treatment, 1994
- Evaluating the Potential Usefulness of New Prognostic and Predictive Indicators on Node-Negative Breast Cancer PatientsJNCI Journal of the National Cancer Institute, 1993
- How to integrate steroid hormone receptor, flow cytometric, and other prognostic information in regard to primary breast cancerCancer, 1993
- Why do so many prognostic factors fail to pan out?Breast Cancer Research and Treatment, 1992
- Long-term prognostic significance of thymidine labelling index in primary breast cancerEuropean Journal Of Cancer, 1992
- Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients.Journal of Clinical Oncology, 1992
- Feasibility and reproducibility of the [3H]‐thymidine labelling index in breast cancerCell Proliferation, 1991
- Treatment of Early-Stage Breast CancerJAMA, 1991
- Proliferative index of breast carcinoma by thymidine labeling: Prognostic power independent of stage, estrogen and progesterone receptorsBreast Cancer Research and Treatment, 1988
- The DNA labelling index: A prognostic factor in node-negative breast cancerBreast Cancer Research and Treatment, 1987